Cited by 5,287MicroRNA in disease regulationPlant Molecular Biology ResearchRNA Interference and Gene Delivery

The DOI matches its Crossref record; 144 of the 146 references it cites were found in a registry or an index; none of the 127 sources its claims cite is checked for support yet.

Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation

Open access
O'Brien, Jacob, Hayder, Heyam, Zayed, Yara, Peng, Chun·2018·Frontiers in Endocrinology

Abstract

MicroRNAs (miRNAs) are a class of non-coding RNAs that play important roles in regulating gene expression. The majority of miRNAs are transcribed from DNA sequences into primary miRNAs and processed into precursor miRNAs, and finally mature miRNAs. In most cases, miRNAs interact with the 3' untranslated region (3' UTR) of target mRNAs to induce mRNA degradation and translational repression. However, interaction of miRNAs with other regions, including the 5' UTR, coding sequence, and gene promoters, have also been reported. Under certain conditions, miRNAs can also activate translation or regulate transcription. The interaction of miRNAs with their target genes is dynamic and dependent on many factors, such as subcellular location of miRNAs, the abundancy of miRNAs and target mRNAs, and the affinity of miRNA-mRNA interactions. miRNAs can be secreted into extracellular fluids and transported to target cells via vesicles, such as exosomes, or by binding to proteins, including Argonautes. Extracellular miRNAs function as chemical messengers to mediate cell-cell communication. In this review, we provide an update on canonical and non-canonical miRNA biogenesis pathways and various mechanisms underlying miRNA-mediated gene regulations. We also summarize the current knowledge of the dynamics of miRNA action and of the secretion, transfer, and uptake of extracellular miRNAs.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This review summarizes microRNA biogenesis, mechanisms of action, dynamic subcellular regulation, and extracellular circulation. It highlights miRNAs as both gene regulators and intercellular signals while noting unresolved questions about nuclear function, translational activation, and secretion/uptake.

Key findings

  • Canonical miRNA biogenesis involves pri-miRNA processing by Drosha/DGCR8, export by XPO5/RanGTP, Dicer cleavage into a mature duplex, and loading of the 5p or 3p strand into AGO1–4; non-canonical pathways include Drosha/DGCR8-independent mirtrons and m7G-capped pre-miRNAs, and Dicer-independent AGO2-dependent processing.
  • Most miRNAs bind 3′ UTR miRNA response elements to induce translational repression and mRNA deadenylation, decapping, and degradation via GW182, PAN2/3, CCR4-NOT, DCP2, and XRN1; binding to 5′ UTR/coding regions can silence, promoter binding can induce transcription, and activation occurs under specific conditions such as serum starvation, cell cycle arrest, oocytes, and amino acid starvation.
  • miRNA action is dynamic: miRISC localizes to rER, P-bodies, stress granules, endosomes, multivesicular bodies, mitochondria, and the nucleus; average polysome occupancy is below 40%, and FANTOM5 data indicate that the top five expressed miRNAs represent on average ~50% of the miRNA pool in a given human cell type, with about half cell-type enriched and one quarter broadly expressed.
  • Extracellular miRNAs are highly stable, resisting room-temperature degradation for up to 4 days and conditions such as boiling, freeze-thaw cycles, and high or low pH; they circulate in vesicles or bound to proteins such as AGO2, HDL, and NPM1, and can act as autocrine, paracrine, or endocrine signals, including via Toll-like receptors.

Methods

  • Narrative review; no primary experimental data, systematic search strategy, or sample size is reported.
  • The main analysis is a thematic synthesis of published literature on canonical and non-canonical biogenesis, miRNA-mediated gene regulation, subcellular dynamics, and extracellular miRNA circulation.
  • Data/sample: not applicable; the paper synthesizes prior studies and includes proposed models in figures.

Limitations

  • The paper states that understanding of when and how miRNAs regulate transcription is limited, conditions for translational activation need further exploration, and mechanisms of extracellular miRNA secretion and uptake are not well understood.
  • The paper notes that many studies use in vitro transfection into immortalized or cancer cell lines, which may not reflect endogenous miRNA functions in vivo, and that chemical tags on miRNAs could affect miRNA:MRE or AGO:miRNA interactions.
  • Evident from the text: as a narrative review, it does not systematically assess evidence quality or quantify effect sizes across the cited literature.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3389/fendo.2018.00402

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 127 cited sources checked · 0 supported · 0 flagged

Show all 65 claims

  • It may state two separate claims as one. 29
  • Probably not a substantial claim. 13
42 of 42
  • The paper relies on this without support.

    The first and last miRNA nucleotides clamp the miRNA within AGO proteins.

    “The first and last miRNA nucleotides clamp the miRNA within AGO proteins”
1 of 1

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • miRNA identifier differs from the cited study

    Minor

    The text attributes suppression of CYP2E1 transcription to miR-522, but the title of the cited study identifies the miRNA as miR-552.

  • Flow condition differs from the cited study

    Minor

    The text describes the cited secretion finding as induced by atheroprotective laminar shear stress, whereas the cited study's title identifies disturbed flow as the inducing condition.

2 of 2

Citations

Cites

Flagged first, then by citations

Show all 146 references

2 of the 146 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Items 801–900 of 1,008

Metadata

Authors
O'Brien, J., Hayder, H., Zayed, Y., & Peng, C.
Affiliations
York University (CA)
Corresponding author
Peng, Chun
Venue
Frontiers in Endocrinology
Published
2018-08-03
Volume
9
Pages
402-402
ISSN
1664-2392 (ISSN-L)
OpenAlex
W2811212358
Cited by
5,287
References
146
Citations by year
2026: 502 · 2025: 781 · 2024: 872 · 2023: 930 · 2022: 906 · 2021: 696 · 2020: 421 · 2019: 149 · 2018: 6
FWCI
33.05
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Endocrinology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Canadian Institutes of Health Research (153146_1, MOP89931, 132565_1, 92222_1, MOP-81370)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Plant Molecular Biology Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords
microRNA biogenesis, microRNA regulation of gene expression, 3' untranslated region, mRNA degradation, protein synthesis inhibition, Argonaute proteins, exosomes, extracellular miRNAs, intercellular communication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review